Yali Sun

Title: The Innovative Contributions of Yali Sun

Introduction

Yali Sun is an accomplished inventor based in Livingston, NJ. She has made notable strides in the realm of pharmaceutical innovations. Her work primarily focuses on developing compositions that hold promise in the treatment of cancer, contributing significantly to the field of medicine.

Latest Patents

Yali Sun holds a patent for her formulation titled "3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione". This patent encompasses pharmaceutical compositions and single-unit dosage forms of the compound along with its enantiomers, mixtures, and various acceptable forms such as salts and solvates. The patented formulation is aimed at providing methods for treating, managing, or preventing cancer, thus reflecting her commitment to advancing healthcare.

Career Highlights

Currently, Yali Sun is associated with Celgene Corporation, a leading biopharmaceutical company renowned for its innovative approaches to treating serious diseases. Throughout her career, she has exemplified dedication to research and development, emphasizing the importance of combining scientific rigor with practical applications to create effective therapies.

Collaborations

Yali has had the privilege of collaborating with distinguished coworkers such as Colin Walters and William Bowen. These partnerships highlight the collaborative environment at Celgene Corporation, fostering innovative research and the development of new therapies.

Conclusion

Yali Sun's contributions to the field of pharmaceuticals, particularly her advancements in cancer treatment formulations, showcase her role as a visionary inventor. Her dedication to improving healthcare through innovation reflects the ongoing evolution in medical science, and her work serves as an inspiring example for aspiring inventors in the pharmaceutical industry.